[topsearch__bar__shortcode]

Why Did Dare Bioscience Inc. (DARE) Stock Drop This Session?

[breadcrumb_custom]

Related Topics

Facebook
Twitter
LinkedIn
WhatsApp

Dare Bioscience Inc. (DARE) shares dropped by -4.82% at $1.58 in Monday’s session. Dare Bioscience stock finished the last trading session at $1.66. The stock recorded a trading volume of 0.4 million shares, which is below the average daily trading volume published for the last 50 days of 6.73 million shares.

The shares of Dare Bioscience have advanced 6.41% in the last five days; however, they have lost -1.78% over the last one month. The stock price has added 0.61% over the last three months and has lost -17.00 percent so far this year. The stock is falling while the company is set to participate in a conference today.

Which meeting DARE will partake in?

Dare Bioscience is a biopharmaceutical organization focused on progressing creative items for ladies’ wellbeing. DARE’s main goal is to recognize, create and bring to advertise an assorted arrangement of separated treatments that focus on ladies’ wellbeing and prosperity, extend treatment choices, and further develop results, principally in the space of contraception, fruitfulness, and vaginal and sexual wellbeing.

It was declared by Dare Bioscience that Sabrina Martucci Johnson, its President and Chief Executive Officer, will take part in the conference planned for today.

  • She will face to face present at the “2022 BIO CEO and Investor Conference” today at 2:15 p.m. EST.
  • The conference is scheduled from February 14-17, 2022 at New York Marriott Marquis and Virtually.
  • On Thursday, February 17, 2022, at 1:00 p.m. EST, The company President will also virtually attend and present in “SVB Leerink Virtual eleventh Annual Global Healthcare Conference”.
  • A filed webcast of Ms. Johnson’s presentation at the SVB Leerink Virtual eleventh Annual Global Healthcare Conference will be accessible until March 3, 2022, under “Introductions, Events and Webcasts” in the Investors segment of the organization’s site.

Company’s other recent presentation

Dare Bioscience CEO as of late presented at the H.C. Wainwright BIOCONNECT 2022 Conference being held practically on January 10, 2022. DARE from that day made her presentation accessible on-interest for meeting members, and under “Introductions, Events and Webcasts” in the Investors part of the organization’s site.

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest Posts